Vivo Capital Fund IX, L.P. (CIK 0001750117)

Latest company ownership

Shares held
3,158,851
Last filed at
Jul 21, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q3 2025Q4
Role: 10% Owner
Shares held
3,015,545
Last filed at
Aug 10, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
Shares held
2,469,001
Last filed at
May 5, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Role: 10% Owner
Shares held
477,091
Last filed at
Mar 25, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 9, 2023 Aug 10, 2023 IO Biotech, Inc. 10% Owner Buy 100.0 +3,157,894 104.72% $6M
May 5, 2022 May 5, 2022 Tarsus Pharmaceuticals, Inc. 10% Owner Sell 40.0 -5,374 -0.22% $65.8K
May 2, 2022 May 4, 2022 Tarsus Pharmaceuticals, Inc. 10% Owner Sell 16.3 -512,956 -17.17% $6.9M
Nov 9, 2021 Nov 12, 2021 IO Biotech, Inc. 10% Owner Buy 100.0 +650,000 27.48% $9.1M
Jun 23, 2021 Jun 25, 2021 Tarsus Pharmaceuticals, Inc. 10% Owner Sell 17.5 -55,684 -1.83% $1.7M
Jun 21, 2021 Jun 25, 2021 Tarsus Pharmaceuticals, Inc. 10% Owner Sell 16.3 -201,620 -6.21% $5.9M
Apr 14, 2021 Apr 16, 2021 Tarsus Pharmaceuticals, Inc. 10% Owner Sell 51.3 -400 -0.01% $12.1K
Mar 23, 2021 Mar 25, 2021 Instil Bio, Inc. 10% Owner Buy 88.8 +300,000 2.46% $6M
Oct 20, 2020 Oct 20, 2020 Tarsus Pharmaceuticals, Inc. 10% Owner Buy 95.0 +250,000 8.35% $4M
Jul 21, 2020 Jul 21, 2020 ALX ONCOLOGY HOLDINGS INC 10% Owner Buy 100.0 +975,000 100.00% $18.5M